Showing results (151-160 of 261) with videos related to
Sort By:
Pageof 27
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 15, 2019
Pruritus in patients with solid tumors: an overlooked supportive care needJaxon J Vallely, Kathryn E Hudson, Susan C Locke, et al.Journal of Pain and Symptom Management|May 2, 2021
Perceptions of Hematology Among Palliative Care Physicians: Results of a Nationwide SurveyWil L Santivasi, Daniel S Childs, Kelly L Wu, et al.Academic Medicine : Journal of the Association of American Medical Colleges|July 2, 2010
A comparative resident site visit project: a novel approach for implementing programmatic change in the duty hours eraMatthew J Crowley, Christina E Barkauskas, F Douglas Srygley, et al.Journal of Agricultural Safety and Health|December 18, 2004
Acute and chronic disability among U.S. farmers and pesticide applicators: the National Health Interview Survey (NHIS)O Gómez-Marín, L E Fleming, D J Lee, et al.Frontiers in Immunology|April 2, 2021
Chitotriosidase Activity Is Counterproductive in a Mouse Model of Systemic CandidiasisNicholas A Schmitz, Ritesh P Thakare, Chun-Shiang Chung, et al.Clinical Trials (London, England)|February 21, 2019
Caregiver-guided pain coping skills training for patients with advanced cancer: Background, design, and challenges for the CaringPals studyLaura S Porter, Gregory Samsa, Jennifer L Steel, et al.Journal of Leukocyte Biology|September 17, 1998
Combinatorial requirements for adhesion molecules in mediating neutrophil emigration during bacterial peritonitis in miceJ P Mizgerd, W M Quinlan, B W LeBlanc, et al.The Oncologist|November 7, 2022
A Systematic Review of Decision Aids in Hematologic Malignancies: What Are Currently Available and What Are We Missing?Janice Zhao, Maya Abdallah, Chandrika Sanapala, et al.Journal of Comparative Effectiveness Research|April 7, 2025
Elranatamab versus physician's choice of treatment in patients with triple-class exposed/refractory multiple myeloma: an updated matching-adjusted indirect comparisonIsha Mol, Yannan Hu, Thomas W LeBlanc, et al.Journal of Blood Medicine|May 19, 2025
Matching-Adjusted Indirect Comparison of Elranatamab versus Teclistamab in Patients with Triple-Class Exposed/Refractory Multiple Myeloma: Updated ResultsIsha Mol, Yannan Hu, Thomas W LeBlanc, et al.Pageof 27